These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 29780795)

  • 1. A Novel
    França TT; Leite LFB; Maximo TA; Lambert CG; Zurro NB; Forte WCN; Condino-Neto A
    Front Pediatr; 2018; 6():130. PubMed ID: 29780795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. X-linked hyper-IgM syndrome with CD40LG mutation: two case reports and literature review in Taiwanese patients.
    Tsai HY; Yu HH; Chien YH; Chu KH; Lau YL; Lee JH; Wang LC; Chiang BL; Yang YH
    J Microbiol Immunol Infect; 2015 Feb; 48(1):113-8. PubMed ID: 23010537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. De novo mutation causing X-linked hyper-IgM syndrome: a family study in Taiwan.
    Ma YC; Lee WI; Shyur SD; Lin SC; Huang LH; Wu JY
    Asian Pac J Allergy Immunol; 2005 Mar; 23(1):53-9. PubMed ID: 15997875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. X-linked hyper-immunoglobulin M syndrome harboring a novel CD40-ligand gene mutation: a case report.
    Ramachandran R; Krishnan Y; Singh P; Kumar A; Mohanty A
    Immunogenetics; 2023 Apr; 75(2):191-194. PubMed ID: 36478253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pitfalls of "hyper"-IgM syndrome: a new CD40 ligand mutation in the presence of low IgM levels. A case report and a critical review of the literature.
    Heinold A; Hanebeck B; Daniel V; Heyder J; Tran TH; Döhler B; Greil J; Müller FM
    Infection; 2010 Dec; 38(6):491-6. PubMed ID: 20981468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial DNA insert into CD40 ligand gene-associated X-linked hyper-IgM syndrome.
    Li X; Xu D; Cheng B; Zhou Y; Chen Z; Wang Y
    Mol Genet Genomic Med; 2021 May; 9(5):e1646. PubMed ID: 33764006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical features and genetic analysis of Taiwanese patients with the hyper IgM syndrome phenotype.
    Lee WI; Huang JL; Yeh KW; Yang MJ; Lai MC; Chen LC; Ou LS; Yao TC; Lin SJ; Jaing TH; Chen SH; Hsieh MY; Yu HH; Chien YH; Shyur SD
    Pediatr Infect Dis J; 2013 Sep; 32(9):1010-6. PubMed ID: 23538518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted gene editing restores regulated CD40L function in X-linked hyper-IgM syndrome.
    Hubbard N; Hagin D; Sommer K; Song Y; Khan I; Clough C; Ochs HD; Rawlings DJ; Scharenberg AM; Torgerson TR
    Blood; 2016 May; 127(21):2513-22. PubMed ID: 26903548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic Analysis of Patients with Two Different Types of Hyper IgM Syndrome.
    Alizadeh Z; Mazinani M; Houshmand M; Shakerian L; Nourizadeh M; Pourpak Z; Fazlollahi MR
    Immunol Invest; 2018 Oct; 47(7):745-753. PubMed ID: 30081731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The polymorphism p.G219R of CD40L does not cause immunological alterations in vivo: conclusions from a X-linked hyper IgM syndrome kindred.
    Martinez-Martinez L; Gonzalez-Santesteban C; Badell I; de la Calle-Martin O
    Mol Immunol; 2012 Oct; 52(3-4):237-41. PubMed ID: 22750225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD40 ligand expression deficiency in a female carrier of the X-linked hyper-IgM syndrome as a result of X chromosome lyonization.
    de Saint Basile G; Tabone MD; Durandy A; Phan F; Fischer A; Le Deist F
    Eur J Immunol; 1999 Jan; 29(1):367-73. PubMed ID: 9933119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. X-linked Hyper IgM Syndrome Presenting as Pulmonary Alveolar Proteinosis.
    Gallagher J; Adams J; Hintermeyer M; Torgerson TR; Lopez-Guisa J; Ochs HD; Szabo S; Salib M; Verbsky J; Routes J
    J Clin Immunol; 2016 Aug; 36(6):564-70. PubMed ID: 27324886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expanding the clinical and genetic spectrum of human CD40L deficiency: the occurrence of paracoccidioidomycosis and other unusual infections in Brazilian patients.
    Cabral-Marques O; Schimke LF; Pereira PV; Falcai A; de Oliveira JB; Hackett MJ; Errante PR; Weber CW; Ferreira JF; Kuntze G; Rosário-Filho NA; Ochs HD; Torgerson TR; Carvalho BT; Condino-Neto A
    J Clin Immunol; 2012 Apr; 32(2):212-20. PubMed ID: 22193914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Respiratory Complications in Patients with Hyper IgM Syndrome.
    Moazzami B; Yazdani R; Azizi G; Kiaei F; Tafakori M; Modaresi M; Shirzadi R; Mahdaviani SA; Sohani M; Abolhassani H; Aghamohammadi A
    J Clin Immunol; 2019 Aug; 39(6):557-568. PubMed ID: 31183658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel CD40LG deletion causes the hyper-IgM syndrome with normal CD40L expression in a 6-month-old child.
    López-Herrera G; Maravillas-Montero JL; Vargas-Hernández A; Berrón-Ruíz L; Ramírez-Sánchez E; Yamazaki-Nakashimada MA; Espinosa-Rosales FJ; Santos-Argumedo L
    Immunol Res; 2015 May; 62(1):89-94. PubMed ID: 25752457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and laboratory findings in hyper-IgM syndrome with novel CD40L and AICDA mutations.
    Aghamohammadi A; Parvaneh N; Rezaei N; Moazzami K; Kashef S; Abolhassani H; Imanzadeh A; Mohammadi J; Hammarström L
    J Clin Immunol; 2009 Nov; 29(6):769-76. PubMed ID: 19575287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First report of the Hyper-IgM syndrome Registry of the Latin American Society for Immunodeficiencies: novel mutations, unique infections, and outcomes.
    Cabral-Marques O; Klaver S; Schimke LF; Ascendino ÉH; Khan TA; Pereira PV; Falcai A; Vargas-Hernández A; Santos-Argumedo L; Bezrodnik L; Moreira I; Seminario G; Di Giovanni D; Raccio AG; Porras O; Weber CW; Ferreira JF; Tavares FS; de Carvalho E; Valente CF; Kuntze G; Galicchio M; King A; Rosário-Filho NA; Grota MB; dos Santos Vilela MM; Di Gesu RS; Lima S; de Souza Moura L; Talesnik E; Mansour E; Roxo-Junior P; Aldave JC; Goudouris E; Pinto-Mariz F; Berrón-Ruiz L; Staines-Boone T; Calderón WO; del Carmen Zarate-Hernández M; Grumach AS; Sorensen R; Durandy A; Torgerson TR; Carvalho BT; Espinosa-Rosales F; Ochs HD; Condino-Neto A
    J Clin Immunol; 2014 Feb; 34(2):146-56. PubMed ID: 24402618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospects for modulating the CD40/CD40L pathway in the therapy of the hyper-IgM syndrome.
    Meng X; Yang B; Suen WC
    Innate Immun; 2018 Jan; 24(1):4-10. PubMed ID: 29132233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel mutation in the CD40 ligand gene in a Chinese boy with X-linked hyper-IgM syndrome.
    Liu PN; Li H; Li Q; Yin ZW; Zhou CY; Jiang MY; Guo X
    Asian Pac J Allergy Immunol; 2014 Sep; 32(3):270-4. PubMed ID: 25268346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two novel CD40LG gene mutations causing X-linked hyper IgM syndrome in Vietnamese patients.
    Lien NTK; Van Anh NT; Chi LQ; Le NNQ; Huyen TT; Mai NTP; Van Tung N; Hoang NH
    Clin Exp Med; 2023 Feb; 23(1):157-161. PubMed ID: 34842998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.